Basis for the discrimination of supercoil handedness during DNA cleavage by human and bacterial type II topoisomerases.
Basis for the discrimination of supercoil handedness during DNA cleavage by human and bacterial type II topoisomerases.
复制标题
人类和细菌 II 型拓扑异构酶 DNA 切割过程中超螺旋旋向判别的基础。
DOI:
10.1093/nar/gkad190
复制
发表时间:
2023
影响因子:
14.9
通讯作者:
Osheroff,Neil
中科院分区:
文献类型:
--
作者:
Jian,JeffreyY;McCarty,KevinD;Byl,JoAnnW;Guengerich,FPeter;Neuman,KeirC;Osheroff,Neil
To perform double-stranded DNA passage, type II topoisomerases generate a covalent enzyme-cleaved DNA complex (i.e. cleavage complex). Although this complex is a requisite enzyme intermediate, it is also intrinsically dangerous to genomic stability. Consequently, cleavage complexes are the targets for several clinically relevant anticancer and antibacterial drugs. Human topoisomerase IIα and IIβ and bacterial gyrase maintain higher levels of cleavage complexes with negatively supercoiled over positively supercoiled DNA substrates. Conversely, bacterial topoisomerase IV is less able to distinguish DNA supercoil handedness. Despite the importance of supercoil geometry to the activities of type II topoisomerases, the basis for supercoil handedness recognition during DNA cleavage has not been characterized. Based on the results of benchtop and rapid-quench flow kinetics experiments, the forward rate of cleavage is the determining factor of how topoisomerase IIα/IIβ, gyrase and topoisomerase IV distinguish supercoil handedness in the absence or presence of anticancer/antibacterial drugs. In the presence of drugs, this ability can be enhanced by the formation of more stable cleavage complexes with negatively supercoiled DNA. Finally, rates of enzyme-mediated DNA ligation do not contribute to the recognition of DNA supercoil geometry during cleavage. Our results provide greater insight into how type II topoisomerases recognize their DNA substrates.